ncRNA name
GAS5
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
miRNA-21
Cancer name
Cervical Cancer
Cancer site
Cervix Uteri
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Down
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
We found that high expression of GAS5 and low expression of miR-21 can enhance the sensitivity of SiHa/cDDP cancer cells to cisplatin.
Tissue resource
cervical cancer and normal cervical tissue specimens
cervical cancer cell lines HeLa
cervical cancer cell lines SiHa
cervical cancer cell lines CaSki
Experiment
qRT-PCR,Western blot,Dual-luciferase reporter assay
Institute
the Third Affiliated Hospital of Guangzhou Medical University
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia